MARKET

COEP

COEP

Coeptis Therapeutics Inc
NASDAQ
12.11
+0.29
+2.45%
After Hours: 12.11 0 0.00% 16:04 02/13 EST
OPEN
11.63
PREV CLOSE
11.82
HIGH
12.40
LOW
11.63
VOLUME
35.28K
TURNOVER
--
52 WEEK HIGH
21.41
52 WEEK LOW
6.26
MARKET CAP
69.78M
P/E (TTM)
-3.4850
1D
5D
1M
3M
1Y
5Y
1D
Coeptis Reprices Equity Awards and Accelerates Option Vesting
TipRanks · 3d ago
Coeptis Therapeutics Launches One-Time Option Repricing and Exchange Program
Reuters · 3d ago
Weekly Report: what happened at COEP last week (0202-0206)?
Weekly Report · 6d ago
Coeptis Therapeutics Shareholders Approve Proposed Merger With Z Squared
Benzinga · 02/05 21:02
Coeptis Shareholders Approve Z Squared Merger
Reuters · 02/05 21:02
COEPTIS RECEIVES SHAREHOLDER APPROVAL TOWARDS Z SQUARED MERGER
Reuters · 02/05 21:00
Press Release: Coeptis Receives Shareholder Approval Towards Z Squared Merger
Dow Jones · 02/05 21:00
Coeptis Shareholders Approve Merger, Spin-Out and Rebranding
TipRanks · 02/04 22:13
More
About COEP
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company. The Company is focused on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed by the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and robotic process automation capabilities. The Company’s subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.

Webull offers Coeptis Therapeutics Holdings Inc stock information, including NASDAQ: COEP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COEP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COEP stock methods without spending real money on the virtual paper trading platform.